VIA Awarded Grant from the Bill & Melinda Gates Foundation to Scale Distribution of Life-saving Maternal and Newborn Health Products.
VIA is thrilled to announce that VIA Global Health has been awarded a two-year grant from the Bill & Melinda Gates Foundation to strengthen distribution channels for maternal and newborn health (MNH) technologies. This grant will enable VIA to expand and build upon our annual growth over the past several years. Below you can learn additional details about the grant and the impact it will have.
- Expanding capacity – support from the Gates Foundation will enable VIA to make key resource investments and hires to increase capacity to our existing successful model. We will build upon our ongoing work by optimizing our platform, expanding distributor outreach in emerging economies and scaling customer-oriented services, all of which will assist in increasing awareness of maternal and newborn health products, facilitate cross-border transactions and reduce barriers to scale and impact between the product suppliers and our global customer network.
- Increasing impact – VIA has already positively impacted over 500,000 patient lives in low-resource and underserved countries, reflecting our commitment to serving local markets in low and middle-income countries through a sustainable business model that also has a sharp focus on impact and contributing to the UN’s Sustainable Development Goals. This grant aims to accelerate VIA’s impact to several million patient lives during this program by increasing customer access to affordable, high-quality MNH products and continue to address the persistent market challenges that prevent life-saving products from being utilized where they are most needed – a priority of both VIA and the Gates Foundation.
VIA’s company leads for the Gates Foundation relationship, CEO Noah Perin and VP of Market Insights Brinnon Mandel, shared their excitement following the announcement. “This is enormous news for VIA as an immediate springboard to growth, but we believe even bigger news for the global health community as a whole as the need for improved distribution has long been overlooked. The investment in VIA is a recognition that without access to medical equipment, health innovations cannot achieve their intended impact, and with this support we will continue to accelerate our mission to enable universal access to critical medical products, information and services for underserved communities.”
Please contact us directly to learn more details about the grant or our work with the Gates Foundation. For media opportunities or to feature our work, please contact [email protected].
VIA Global Health is reinventing the global healthcare supply chain with a vision to scale health innovation to the 6 billion people living in emerging economies. Leveraging our e-commerce and logistics platform, VIA connects global healthcare equipment suppliers to a network of verified local distributors – with a mission to create universal access to the tools that enable quality healthcare. For media inquiries please email [email protected]
VIA Global Health joins partnership led by African Pandemic Response Alliance (APRA) and Save the Children to combat COVID-19 throughout Africa.
VIA has been working to address the COVID-19 outbreak globally, with a focus throughout Africa, by delivering critical preventive, diagnostic and treatment medical supplies throughout the pandemic. Now, in partnering with private organizations like African Pandemic...
VIA Global Health’s mission is to create universal access to the tools that enable quality healthcare, and with an emphasis on lower resource communities, we have now just passed yet another important milestone in that vision – positively impacting the lives of over...
Noah Perin Invited as Speaker at Devex ‘Prescription for Progress: Bringing Health Solutions to Scale’ Conference in February 2020.
VIA’s CEO, Noah Perin, will be joining a list of thought leaders in the health industry at the Devex ‘Prescription for Progress: Bringing Health Solutions to Scale’ conference on February 20, 2020 in San Francisco, representing the often overlooked but critical role...